Assenagon Asset Management’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,922
Closed -$93.1K 1154
2025
Q4
$93.1K Hold
13,922
﹤0.01% 1135
2025
Q3
$61K Buy
13,922
+10,242
+278% +$48.6K ﹤0.01% 1157
2025
Q2
$16.3K Sell
3,680
-1,763
-32% -$7.37K ﹤0.01% 1148
2025
Q1
$30.8K Sell
5,443
-1,537
-22% -$19.7K ﹤0.01% 1142
2024
Q4
$147K Sell
6,980
-13,252
-66% -$304K ﹤0.01% 1287
2024
Q3
$544K Sell
20,232
-2,538
-11% -$74.8K ﹤0.01% 1232
2024
Q2
$649K Buy
22,770
+15,022
+194% +$527K ﹤0.01% 1192
2024
Q1
$329K Hold
7,748
﹤0.01% 1273
2023
Q4
$415K Sell
7,748
-2,127
-22% -$96K ﹤0.01% 1277
2023
Q3
$425K Sell
9,875
-3,590
-27% -$166K ﹤0.01% 1228
2023
Q2
$739K Buy
13,465
+7,250
+117% +$398K ﹤0.01% 1045
2023
Q1
$261K Buy
+6,215
New +$184K ﹤0.01% 1329
2022
Q4
Sell
-2,238
Closed -$57K 1399
2022
Q3
$57K Sell
2,238
-2,220
-50% -$73.4K ﹤0.01% 1305
2022
Q2
$160K Buy
4,458
+1,393
+45% +$62.9K ﹤0.01% 1396
2022
Q1
$190K Sell
3,065
-9,499
-76% -$562K ﹤0.01% 1363
2021
Q4
$886K Buy
12,564
+7,028
+127% +$500K ﹤0.01% 1070
2021
Q3
$386K Buy
+5,536
New +$441K ﹤0.01% 1103
2020
Q3
Sell
-23,400
Closed -$725K 1221
2020
Q2
$725K Buy
+23,400
New +$630K 0.01% 920
2019
Q4
Sell
-44,035
Closed -$1.35M 834
2019
Q3
$1.35M Buy
44,035
+42,738
+3,295% +$1.06M 0.01% 493
2019
Q2
$26K Sell
1,297
-6,978
-84% -$204K ﹤0.01% 981
2019
Q1
$357K Buy
+8,275
New +$300K ﹤0.01% 847

Other funds holding HBIO